Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Factors associated with mortality in transplant patients with invasive aspergillosis.

Baddley JW, Andes DR, Marr KA, Kontoyiannis DP, Alexander BD, Kauffman CA, Oster RA, Anaissie EJ, Walsh TJ, Schuster MG, Wingard JR, Patterson TF, Ito JI, Williams OD, Chiller T, Pappas PG.

Clin Infect Dis. 2010 Jun 15;50(12):1559-67. doi: 10.1086/652768.

2.

Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis.

Baddley JW, Andes DR, Marr KA, Kauffman CA, Kontoyiannis DP, Ito JI, Schuster MG, Brizendine KD, Patterson TF, Lyon GM, Boeckh M, Oster RA, Chiller T, Pappas PG.

Med Mycol. 2013 Feb;51(2):128-35. doi: 10.3109/13693786.2012.690108. Epub 2012 Jun 11.

PMID:
22680976
3.

Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: a 1-year retrospective study of consecutive patients at French transplantation centers.

Cordonnier C, Ribaud P, Herbrecht R, Milpied N, Valteau-Couanet D, Morgan C, Wade A; Société Française de Greffe de Moelle et de Thérapie Cellulaire..

Clin Infect Dis. 2006 Apr 1;42(7):955-63. Epub 2006 Feb 22.

PMID:
16511759
4.

Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality.

Upton A, Kirby KA, Carpenter P, Boeckh M, Marr KA.

Clin Infect Dis. 2007 Feb 15;44(4):531-40. Epub 2007 Jan 9.

PMID:
17243056
5.

Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10-year, single-center experience.

Neofytos D, Treadway S, Ostrander D, Alonso CD, Dierberg KL, Nussenblatt V, Durand CM, Thompson CB, Marr KA.

Transpl Infect Dis. 2013 Jun;15(3):233-42. doi: 10.1111/tid.12060. Epub 2013 Feb 21.

6.

Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.

Neofytos D, Horn D, Anaissie E, Steinbach W, Olyaei A, Fishman J, Pfaller M, Chang C, Webster K, Marr K.

Clin Infect Dis. 2009 Feb 1;48(3):265-73. doi: 10.1086/595846. Erratum in: Clin Infect Dis. 2009 Mar 1;48(5):690.

PMID:
19115967
7.

Invasive aspergillosis in hematopoietic stem cell and solid organ transplantation.

Salman N, Törün SH, Budan B, Somer A.

Expert Rev Anti Infect Ther. 2011 Mar;9(3):307-15. doi: 10.1586/eri.11.13. Review.

PMID:
21417870
8.

Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients.

Neofytos D, Fishman JA, Horn D, Anaissie E, Chang CH, Olyaei A, Pfaller M, Steinbach WJ, Webster KM, Marr KA.

Transpl Infect Dis. 2010 Jun;12(3):220-9. doi: 10.1111/j.1399-3062.2010.00492.x. Epub 2010 Jan 25.

PMID:
20113459
9.

Presumptive treatment strategy for aspergillosis in allogeneic haematopoietic stem cell transplant recipients.

Oshima K, Kanda Y, Asano-Mori Y, Nishimoto N, Arai S, Nagai S, Sato H, Watanabe T, Hosoya N, Izutsu K, Asai T, Hangaishi A, Motokura T, Chiba S, Kurokawa M.

J Antimicrob Chemother. 2007 Aug;60(2):350-5. Epub 2007 Jun 21.

PMID:
17584800
10.

Increasing incidence of invasive aspergillosis in pediatric hematology oncology patients over the last decade: a retrospective single centre study.

Rubio PM, Sevilla J, González-Vicent M, Lassaletta A, Cuenca-Estrella M, Díaz MA, Riesco S, Madero L.

J Pediatr Hematol Oncol. 2009 Sep;31(9):642-6. doi: 10.1097/MPH.0b013e3181acd956.

PMID:
19684521
11.

Invasive aspergillosis in hematopoietic stem cell transplant recipients: a retrospective analysis.

Carvalho-Dias VM, Sola CB, Cunha CA, Shimakura SE, Pasquini R, Queiroz-Telles Fd.

Braz J Infect Dis. 2008 Oct;12(5):385-9.

12.

Outcome analysis of invasive aspergillosis in hematologic malignancy and hematopoietic stem cell transplant patients: the role of novel antimold azoles.

Ramos ER, Jiang Y, Hachem R, Kassis C, Kontoyiannis DP, Raad I.

Oncologist. 2011;16(7):1049-60. doi: 10.1634/theoncologist.2010-0290. Epub 2011 Jun 9.

14.

Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry.

Steinbach WJ, Marr KA, Anaissie EJ, Azie N, Quan SP, Meier-Kriesche HU, Apewokin S, Horn DL.

J Infect. 2012 Nov;65(5):453-64. doi: 10.1016/j.jinf.2012.08.003. Epub 2012 Aug 13.

PMID:
22898389
15.

Adult patients with respiratory syncytial virus infection: impact of solid organ and hematopoietic stem cell transplantation on outcomes.

Pilie P, Werbel WA, Riddell J 4th, Shu X, Schaubel D, Gregg KS.

Transpl Infect Dis. 2015 Aug;17(4):551-7. doi: 10.1111/tid.12409. Epub 2015 Jul 6.

16.
17.

A risk profile for invasive aspergillosis in liver transplant recipients.

Rosenhagen M, Feldhues R, Schmidt J, Hoppe-Tichy T, Geiss HK.

Infection. 2009 Aug;37(4):313-9. doi: 10.1007/s15010-008-8124-x. Epub 2009 Jul 23.

PMID:
19629387
18.

Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey.

Sinkó J, Csomor J, Nikolova R, Lueff S, Kriván G, Reményi P, Bátai A, Masszi T.

Transpl Infect Dis. 2008 Apr;10(2):106-9. Epub 2007 Jul 1.

PMID:
17605727
19.

Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET).

Kauffman CA, Freifeld AG, Andes DR, Baddley JW, Herwaldt L, Walker RC, Alexander BD, Anaissie EJ, Benedict K, Ito JI, Knapp KM, Lyon GM, Marr KA, Morrison VA, Park BJ, Patterson TF, Schuster MG, Chiller TM, Pappas PG.

Transpl Infect Dis. 2014 Apr;16(2):213-24. doi: 10.1111/tid.12186. Epub 2014 Mar 4.

20.

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

Marr KA, Carter RA, Boeckh M, Martin P, Corey L.

Blood. 2002 Dec 15;100(13):4358-66. Epub 2002 Aug 22.

Supplemental Content

Support Center